T Wave Alternans in Hemodialysis

The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

End Stage Renal Disease Cardiovascular Diseases Chronic Disease Congestive Heart Failure Coronary Disease Coronary Heart Disease Death Death, Sudden Death, Sudden, Cardiac Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Heart Arrest Heart Diseases Heart Failure Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Myocardial Ischemia Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Indiana University School of Medicine

Indianapolis, Indiana, 46032, United States

About this study

One-third to one-quarter of hemodialysis patients die of sudden cardiac death (SCD). The hemodialysis procedure may theoretically increase the risk of SCD. This study uses T wave alternans, a noninvasive marker of SCD, to objectively determine whether the hemodialysis procedure alters the risk of SCD in hemodialysis patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older
Normal sinus rhythm

Exclusion criteria

Inability to give written informed consent
Active cardiac ischemia
Pacemaker
Inability to perform a brief walking treadmill test

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Collaborators

Dialysis Clinic, Inc.

Registry information

Official study title

Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients

Important dates

Study start: 2005
Study completion: 2008
First posted: Feb 27, 2006
Registry last updated: Jun 20, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed